Fluoxetine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder, OCD, panic disorder, bulimia nervosa, and premenstrual dysphoric disorder. Known for its exceptionally long half-life, which reduces the risk of discontinuation syndrome compared to other SSRIs. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder, OCD, panic disorder, bulimia nervosa, and premenstrual dysphoric disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 20–80 mg daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete sodium, folate. This profile indexes 10 sources.
- Nausea
- Insomnia
- Anxiety or nervousness
- Concurrent MAOI use (within 14 days; allow 5 weeks washout after stopping fluoxetine)
- Concurrent pimozide or thioridazine use
The bottom line
Evidence rating strong. Most-documented uses: depression symptom relief, ocd symptom reduction, panic attack prevention. 10 sources indexed (1991–2023), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively inhibits the reuptake of serotonin (5-HT) by blocking the serotonin transporter (SERT). Its active metabolite norfluoxetine also potently inhibits SERT, contributing to the drug's prolonged duration of action. Also a potent inhibitor of CYP2D6, leading to clinically significant drug interactions with CYP2D6 substrates (e.g., codeine, tamoxifen, TCAs).
Dosing & protocol.
Can be taken with or without food. Morning dosing is generally preferred due to activating properties.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Sodium
SignificantSSRI-induced SIADH can lower serum sodium, especially in older adults and during the first weeks of therapy.
Folate
MildLower folate status is associated with poorer SSRI response and may be reduced in some chronic users through altered one-carbon metabolism.
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trialsPMIDFornaro M, Mondin AM, Billeci M, Fusco A et al. · Journal of Affective Disorders · 2023
Fluoxetine is the most studied medication for bulimia nervosa and binge eating disorder, with evidence supporting its efficacy in reducing binge-eating episodes and purging behaviors
- 2Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trialsPMIDMead GE, Legg L, Tilney R et al. · International journal of stroke : official journal of the International Stroke Society · 2020
Mead GE, Legg L, Tilney R et al.. Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials. International journal of stroke : official journal of the International Stroke Society. 2020
- 3Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studiesPMIDGao SY, Wu QJ, Zhang TN et al. · British journal of clinical pharmacology · 2017
Gao SY, Wu QJ, Zhang TN et al.. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. British journal of clinical pharmacology. 2017
- 4Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysisPMIDCipriani A, Zhou X, Del Giovane C, Hetrick SE et al. · Lancet · 2016
Fluoxetine was the only antidepressant with a favorable efficacy-tolerability balance for children and adolescents with major depression, supporting its status as first-line pharmacotherapy in this population
- 5Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depressionPMIDBeasley CM Jr, Dornseif BE, Bosomworth JC et al. · BMJ (Clinical research ed.) · 1991
Beasley CM Jr, Dornseif BE, Bosomworth JC et al.. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ (Clinical research ed.). 1991
Reviews & position papers
2- 6Fluoxetine and the mitochondria: A review of the toxicological aspectsPMIDde Oliveira MR · Toxicology letters · 2016
de Oliveira MR. Fluoxetine and the mitochondria: A review of the toxicological aspects. Toxicology letters. 2016
- 7Fluoxetine: a five-year reviewPMIDStokes PE · Clinical therapeutics · 1993
Stokes PE. Fluoxetine: a five-year review. Clinical therapeutics. 1993
Reference material
3- 8Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018.Source linkedPMID
- 9Tollefson GD et al. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr. 1995.Source linkedPMID
- 10Yalin N et al. Treatment of bipolar depression: results from a comprehensive network meta-analysis and updated systematic review. Eur Neuropsychopharmacol. 2026.Source linkedPMID
Common questions.
Quick answers about Fluoxetine, drawn from the data on this page.
What is Fluoxetine?
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder, OCD, panic disorder, bulimia nervosa, and premenstrual dysphoric disorder. Known for its exceptionally long half-life, which reduces the risk of discontinuation syndrome compared to other SSRIs. Dosage must be determined by your prescribing physician.
What is Fluoxetine used for?
Commonly cited benefits of Fluoxetine include: Depression symptom relief; OCD symptom reduction; Panic attack prevention; Bulimia nervosa treatment; Premenstrual dysphoric disorder relief. NutriStack rates the overall evidence as strong.
What is a typical dose of Fluoxetine?
A typical adult dose of Fluoxetine is 20–80 mg daily (as prescribed by your physician). The commonly recommended form is Capsule, tablet, or oral solution. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Fluoxetine?
Reported side effects include nausea, insomnia, anxiety or nervousness, sexual dysfunction, headache, decreased appetite. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Fluoxetine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Fluoxetine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.